. Author manuscript; available in PMC: 2017 Dec 1.

Published in final edited form as: J Am Soc Hypertens. 2016 Nov 9;10(12):930–938.e9. doi: 10.1016/j.jash.2016.10.010

Table 4. Mean Cornell voltage for all treatment arms, by comparison group^*.

		LVH by Cornell voltage, mean (SD) in μV, N

Treatment Group	Baseline	2-years	Baseline	4-years
All treatment arms combined	1447 (632), 18,126	1432 (627), 18,126	1446 (625), 15,241	1444 (643), 15,241
Chlorthalidone	1448 (640), 8,403	1429 (628), 8,403	1446 (629), 7,103	1445 (642), 7,103
Amlodipine	1456 (632), 4,952	1428 (618), 4,952	1455 (625), 4,190	1438 (644), 4,190
Lisinopril	1437 (619), 4,771	1440 (634), 4,771	1437 (619), 3,948	1447 (643), 3,948

Included individuals must have the following: a valid Cornell voltage on ECG, no Cornell voltage suppression codes at the specific time point(s) referenced, and have these measurements for both time point(s) referenced i.e. the intersection of individuals at both time points 1 mm = 100 μV

Table 4. Mean Cornell voltage for all treatment arms, by comparison group*.

Table 4. Mean Cornell voltage for all treatment arms, by comparison group^*.